Superbranche Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$13.5M
- Investors
-
6
Superbranche General Information
Description
Developer of therapeutic and diagnostic applications designed for accessibility and detection of the tumor beforehand. The company's platform brings targeted diagnostic and image-guided therapy nanomaterials to clinics based on its proprietary technology, enabling patients to detect and treat metastases early.
Contact Information
Website
www.superbranche.comCorporate Office
- ISIS 2 8 Allee Gaspard Monge
- 67000 Strasbourg
- France
Corporate Office
- ISIS 2 8 Allee Gaspard Monge
- 67000 Strasbourg
- France
Superbranche Timeline
Superbranche Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 04-Feb-2025 | $13.5M | Completed | Pre-Clinical Trials | ||
| 5. Early Stage VC | 24-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Jan-2022 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 01-Jan-2020 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Superbranche Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Superbranche Patents
Superbranche Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025511985-A | Composition of dispersions for biomedical applications, process for their preparation and use thereof - patents.com | Pending | 14-Apr-2022 | ||
| AU-2023251929-A1 | Compositions of dispersed systems for biomedical applications, process for their preparation and uses thereof | Pending | 14-Apr-2022 | ||
| EP-4260876-A1 | Compositions of dispersed systems for biomedical applications, process for their preparation and uses thereof | Inactive | 14-Apr-2022 | ||
| EP-4507743-A1 | Compositions of dispersed systems for biomedical applications, process for their preparation and uses thereof | Pending | 14-Apr-2022 | ||
| US-20250375539-A1 | Compositions of dispersed systems for biomedical applications, process for their preparation and uses thereof | Pending | 14-Apr-2022 | A61K49/226 |
Superbranche Signals
Superbranche Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Capital Grand Est | PE/Buyout | Minority | ||
| Critical Path Ventures | Venture Capital | Minority | ||
| La Synapse | Accelerator/Incubator | |||
| Alsace Business Angels | Angel Group | Minority | ||
| Quest for Health | Accelerator/Incubator |
Superbranche FAQs
-
When was Superbranche founded?
Superbranche was founded in 2019.
-
Where is Superbranche headquartered?
Superbranche is headquartered in Strasbourg, France.
-
What is the size of Superbranche?
Superbranche has 10 total employees.
-
What industry is Superbranche in?
Superbranche’s primary industry is Discovery Tools (Healthcare).
-
Is Superbranche a private or public company?
Superbranche is a Private company.
-
What is Superbranche’s current revenue?
The current revenue for Superbranche is .
-
How much funding has Superbranche raised over time?
Superbranche has raised $15.3M.
-
Who are Superbranche’s investors?
Capital Grand Est, Critical Path Ventures, La Synapse, Alsace Business Angels, and Quest for Health are 5 of 6 investors who have invested in Superbranche.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process